Cirrhosis Increasing in Hepatitis C Patients, According to Large US Study

A High-Tech Blood Test That May Detect Cancer Early
March 13, 2017
Most boomers infected with liver-damaging hepatitis C virus do not know it
March 14, 2017
Show all

Cirrhosis Increasing in Hepatitis C Patients, According to Large US Study

Cirrhosis in Americans with hepatitis C has gone up between 2006 and 2014.

The past decade has seen a nearly 40 percent increase in the prevalence of cirrhosis among people with hepatitis C in the U.S., a new study found. The reasons remain uncertain, however.

The study, titled “Hepatitis C Complications: Prevalence and Disparities in a Large US Cohort 2006-2014” (abstract #180) was presented at The Liver Meeting 2016, held by the American Association for the Study of Liver Diseases (AASLD).

Cirrhosis has long been linked to hepatitis C, but to what extent had been uncertain. To find out, a team led by Stuart C. Gordon, MD, and others analyzed the prevalence of cirrhosis; decompensated cirrhosis — the development of jaundice, ascites, variceal hemorrhage, or hepatic encephalopathy — and the incidence of death among 11,169 American hepatitis C patients between 2006 and 2014.

The team assessed the annual change in percentage between several different points in time to identify trends in prevalence.

Cirrhosis was found to be more prevalent among hepatitis C patients in 2014, when it was at 28.5 percent, than in 2006 (20.5 percent), with the highest increase seen from 2006 to 2007.

The prevalence of decompensated cirrhosis varied according to the age of patients and increased by about 2 percent a year, but the increase was seen only in patients over age 60. It remained fairly steady in younger patients.

Read full article: Cirrhosis Increasing in Hepatitis C Patients, According to Large US Study

Read Full Article: Cirrhosis Increasing in Hepatitis C Patients, According to Large US Study

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.